NO995436D0 - Etylenglykolestere av monohydrobenzoporfyrin derivater som fotoaktive midler - Google Patents

Etylenglykolestere av monohydrobenzoporfyrin derivater som fotoaktive midler

Info

Publication number
NO995436D0
NO995436D0 NO995436A NO995436A NO995436D0 NO 995436 D0 NO995436 D0 NO 995436D0 NO 995436 A NO995436 A NO 995436A NO 995436 A NO995436 A NO 995436A NO 995436 D0 NO995436 D0 NO 995436D0
Authority
NO
Norway
Prior art keywords
ethylene glycol
glycol esters
photoactive agents
pdt
chem
Prior art date
Application number
NO995436A
Other languages
English (en)
Other versions
NO995436L (no
NO314264B1 (no
Inventor
Ethan Sternberg
David Dolphin
Julia G Levy
Anna M Richter
Elizabeth M Waterfield
David W C Hunt
Ashok Jain
Original Assignee
Qlt Phototherapeutics Inc
Univ British Columbia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Qlt Phototherapeutics Inc, Univ British Columbia filed Critical Qlt Phototherapeutics Inc
Publication of NO995436D0 publication Critical patent/NO995436D0/no
Publication of NO995436L publication Critical patent/NO995436L/no
Publication of NO314264B1 publication Critical patent/NO314264B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Steroid Compounds (AREA)
NO19995436A 1997-05-07 1999-11-05 Etylenglykolestere av monohydrobenzoporfyrinderivater, anvendelse derav samt farmasöytisk blanding NO314264B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US85249497A 1997-05-07 1997-05-07
PCT/CA1998/000468 WO1998050387A1 (en) 1997-05-07 1998-05-06 Ethylene glycol esters of monohydrobenzoporphyrin derivatives as photoactive agents

Publications (3)

Publication Number Publication Date
NO995436D0 true NO995436D0 (no) 1999-11-05
NO995436L NO995436L (no) 2000-01-04
NO314264B1 NO314264B1 (no) 2003-02-24

Family

ID=25313492

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19995436A NO314264B1 (no) 1997-05-07 1999-11-05 Etylenglykolestere av monohydrobenzoporfyrinderivater, anvendelse derav samt farmasöytisk blanding

Country Status (21)

Country Link
US (2) US5929105A (no)
EP (2) EP0983273B8 (no)
JP (1) JP3378889B2 (no)
KR (1) KR100397131B1 (no)
CN (1) CN1113882C (no)
AR (1) AR012673A1 (no)
AT (1) ATE211473T1 (no)
AU (1) AU741070B2 (no)
CA (1) CA2284879C (no)
CZ (1) CZ294715B6 (no)
DE (1) DE69803376T2 (no)
DK (1) DK0983273T3 (no)
ES (2) ES2437790T3 (no)
HK (1) HK1042439B (no)
HU (1) HU221754B1 (no)
IL (1) IL132066A (no)
NO (1) NO314264B1 (no)
NZ (1) NZ338031A (no)
PL (1) PL202341B1 (no)
PT (1) PT983273E (no)
WO (1) WO1998050387A1 (no)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6756396B1 (en) * 1997-05-07 2004-06-29 Qlt Inc. Ethylene glycol esters as photoactive agents
US6364907B1 (en) 1998-10-09 2002-04-02 Qlt Inc. Method to prevent xenograft transplant rejection
US6331235B1 (en) * 1998-12-11 2001-12-18 The University Of British Columbia Chiral separation of benzoporphyrin derivative mono-and di-acids by laser-induced fluorescence capillary electrophoresis
US6344050B1 (en) 1998-12-21 2002-02-05 Light Sciences Corporation Use of pegylated photosensitizer conjugated with an antibody for treating abnormal tissue
US6602274B1 (en) * 1999-01-15 2003-08-05 Light Sciences Corporation Targeted transcutaneous cancer therapy
AU2412800A (en) * 1999-01-15 2000-08-01 Light Sciences Corporation Noninvasive vascular therapy
AU2789900A (en) * 1999-02-26 2000-09-21 Qlt Phototherapeutics, Inc. Photodynamic therapy in combination with apoptosis inducing factors
GB9905911D0 (en) 1999-03-15 1999-05-05 Photocure As Method
US6609014B1 (en) 1999-04-14 2003-08-19 Qlt Inc. Use of PDT to inhibit intimal hyperplasia
US20020022032A1 (en) * 1999-04-23 2002-02-21 Curry Patrick Mark Immuno-adjuvant PDT treatment of metastatic tumors
US20040208855A1 (en) * 1999-11-17 2004-10-21 Allison Beth Anne Use of PDT to inhibit intimal hyperplasia
US7122568B1 (en) 1999-11-17 2006-10-17 Qlt, Inc. Use of low-dose PDT to inhibit restenosis
JP2003519670A (ja) * 2000-01-12 2003-06-24 ライト サイエンシーズ コーポレイション 眼疾患の新規処置
AU2001258095A1 (en) * 2000-05-08 2001-11-20 The University Of British Columbia Drug delivery systems for photodynamic therapy
CA2408332C (en) 2000-05-08 2011-02-15 The University Of British Columbia Supports for photosensitizer formulations
DK1339862T3 (en) * 2000-11-29 2014-02-17 Pci Biotech As PHOTO CHEMICAL INTERNALISATION VIRUS-MEDIATED MOLECULAR-DELIVERY INTO cytosol
AU2085302A (en) * 2000-11-29 2002-06-11 Norwegian Radium Hospital Res Photochemical internalization for delivery of molecules into the cytosol
US6984395B2 (en) * 2001-04-11 2006-01-10 Qlt, Inc. Drug delivery system for hydrophobic drugs
CA2448562A1 (en) * 2001-05-31 2002-12-05 Miravant Pharmaceuticals, Inc. Metallotetrapyrrolic photosensitizing agents for use in photodynamic therapy
WO2003017846A1 (en) * 2001-08-22 2003-03-06 Montana State University-Bozeman Porphyrins with enhanced multi-photon absorption cross-sections for photodynamic therapy
US20040013717A1 (en) * 2001-11-02 2004-01-22 Allen Theresa Mary PEG-lipid containing formulations
US7264629B2 (en) 2001-11-09 2007-09-04 Qlt, Inc. Photodynamic therapy for the treatment of hair loss
DE60225169D1 (de) * 2001-11-09 2008-04-03 Quadra Logic Tech Inc Photodynamische therapie zur behandlung von haarausfall
CA2437638A1 (en) * 2003-08-20 2005-02-20 John Robert North Photodynamic therapy
CA2457214A1 (en) 2004-02-06 2005-08-06 Qlt Inc. Photodynamic therapy for the treatment of acne
US20120034157A1 (en) * 2010-08-03 2012-02-09 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Artificial cells
CN105017187B (zh) 2009-07-08 2017-10-24 德米拉(加拿大)公司 用于治疗皮肤病症或疾病状态的tofa类似物
PL2531206T3 (pl) 2010-02-04 2017-12-29 Morphotek, Inc. Polipeptydy i koniugaty chlorotoksyny i ich zastosowanie
CA2824768A1 (en) 2011-01-13 2012-07-19 Qlt Inc. Pharmaceutical compositions for topical delivery of photosensitizers and uses thereof
WO2013003507A1 (en) 2011-06-27 2013-01-03 Morphotek, Inc. Multifunctional agents
EP2771688B1 (en) 2011-10-25 2018-09-26 Memorial Sloan-Kettering Cancer Center Free psa antibodies as diagnostics, prognostics and therapeutics for prostate cancer
AU2013290140A1 (en) 2012-07-11 2015-01-29 Dermira, Inc. Pharmaceutical compositions for topical delivery of photosensitizers and uses thereof
CA2889756C (en) 2012-10-26 2023-03-14 Memorial Sloan-Kettering Cancer Center Thiohydantoin compounds as androgen receptor modulators
CA3142856A1 (en) 2013-12-23 2015-07-02 Memorial Sloan-Kettering Cancer Center Methods and compositions for treating cancer using peptide nucleic acid-based agents

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5171749A (en) 1987-01-20 1992-12-15 University Of British Columbia Wavelength-specific cytotoxic agents
US5095030A (en) * 1987-01-20 1992-03-10 University Of British Columbia Wavelength-specific cytotoxic agents
US5283255A (en) * 1987-01-20 1994-02-01 The University Of British Columbia Wavelength-specific cytotoxic agents
US4920143A (en) * 1987-04-23 1990-04-24 University Of British Columbia Hydro-monobenzoporphyrin wavelength-specific cytotoxic agents
US4883790A (en) 1987-01-20 1989-11-28 University Of British Columbia Wavelength-specific cytotoxic agents
EP0476011A1 (en) * 1989-06-07 1992-03-25 The University Of British Columbia Photosensitizing diels-alder porphyrin derivatives
US5498710A (en) * 1994-04-22 1996-03-12 Health Research, Inc. Alkyl ether analogues of benzoporphyrin derivatives
PT983272E (pt) * 1997-05-07 2004-03-31 Univ British Columbia Nova classe de compostos fotoactivos derivados de benzoporfirina

Also Published As

Publication number Publication date
DE69803376D1 (de) 2002-02-28
HUP0003604A3 (en) 2002-04-29
US6153639A (en) 2000-11-28
EP1177795B1 (en) 2013-09-11
IL132066A (en) 2008-06-05
DE69803376T2 (de) 2002-08-14
AR012673A1 (es) 2000-11-08
US5929105A (en) 1999-07-27
ES2437790T3 (es) 2014-01-14
CZ294715B6 (cs) 2005-02-16
ES2171022T3 (es) 2002-08-16
JP2001507369A (ja) 2001-06-05
CA2284879A1 (en) 1998-11-12
EP0983273A1 (en) 2000-03-08
PT983273E (pt) 2002-06-28
HU221754B1 (hu) 2002-12-28
EP0983273B1 (en) 2002-01-02
CN1113882C (zh) 2003-07-09
JP3378889B2 (ja) 2003-02-17
PL202341B1 (pl) 2009-06-30
NO995436L (no) 2000-01-04
WO1998050387A1 (en) 1998-11-12
HUP0003604A2 (hu) 2001-02-28
KR100397131B1 (ko) 2003-09-13
AU741070B2 (en) 2001-11-22
AU7420798A (en) 1998-11-27
EP0983273B8 (en) 2002-10-09
IL132066A0 (en) 2001-03-19
CA2284879C (en) 2005-10-25
EP1177795A2 (en) 2002-02-06
CN1254339A (zh) 2000-05-24
NZ338031A (en) 2001-04-27
HK1042439B (zh) 2014-02-28
CZ392399A3 (cs) 2000-02-16
PL336790A1 (en) 2000-07-17
ATE211473T1 (de) 2002-01-15
NO314264B1 (no) 2003-02-24
KR20010012331A (ko) 2001-02-15
EP1177795A3 (en) 2002-05-29
DK0983273T3 (da) 2002-04-22

Similar Documents

Publication Publication Date Title
NO995436D0 (no) Etylenglykolestere av monohydrobenzoporfyrin derivater som fotoaktive midler
NO20040822L (no) Forbindelse.
AU2003263878A1 (en) Analogs of indole-3-carbinol metabolites as chemotherapeutic and chemopreventive agents
BR0206159A (pt) Derivados da n(fenilsulfonil)glicina e sua utilização terapêutica
NO952854L (no) 1-arylpyrimidin-derivater
CA2229077A1 (en) Lipid metabolism improving agent
AU4723997A (en) Radicicol derivatives
NZ236034A (en) Pharmaceutical compositions containing imidazole derivatives; topical compositions for treating glaucoma
NZ334961A (en) Biphenyl derivatives substituted by an aromatic or heteroaromatic radical and pharmaceutical and cosmetic compositions containing same
AU2722095A (en) Novel pyrrolocarbazoles
ATE195520T1 (de) Kojic säure derivate als hautpigmentierungsmittel
NO158622C (no) Analogifremgangsmaate for fremstilling av benzosyrederivater med antimikrobiell aktivitet.
EP0503079A4 (en) Pyridazinone-substituted ethynylphenyl derivative and remedy for circulatory organ disease containing the same as active ingredient
DE69603771T2 (de) Substituierte Indenoylguanidines mit antiarrhythmischer und cardioprotektiver Wirkung
EP1149832A4 (en) BENZAMIDE DERIVATIVES AND MEDICINAL PRODUCTS CONTAINING THEM
AU7424394A (en) 3- or 4-glycosyloxybenzopyran derivatives and antiallergic agents containing the derivatives as active ingredients
NO20003138L (no) Ny anvendelse av lokalanestetika mot vaskulære hodepiner
ES2105959B1 (es) Derivados de 1,4-dioxido de quinoxalina, procedimiento de preparacion y de utilizacion.
NO172541C (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyridoindol-derivater
FI903779A0 (fi) S-substituerade betatioacrylamider och deras anvaendning som mikrobicider.
AU686104B2 (en) Substituted amidinonaphthyl ester derivatives
EP2266566A3 (en) Nicotinamide derivatives and their use as therapeutic agents
DK0551844T3 (da) Svovlholdige galdesyrederivater
AU1651201A (en) Amidinophenylpyruvic acid derivative
DE69914563D1 (de) Azaindol derivate und ihre Verwendung als antithrombotische Wirkstoffe

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: THE UNIVERSITY OF BRITISH COLUMBIA, CA

MM1K Lapsed by not paying the annual fees